Travere Therapeutics Inc. buy klostergang
Start price
01.07.19
/
50%
€19.10
Target price
04.11.21
€33.37
Performance (%)
-35.06%
End price
17.06.21
€12.40
Summary
This prediction ended on 17.06.21 with a price of €12.40. The BUY prediction by klostergang for Travere Therapeutics Inc. performed very badly with a performance of -35.06%. klostergang has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Travere Therapeutics Inc. | - | - | 33.333% | - |
| iShares Core DAX® | -1,03 % | -9,17 % | -1,56 % | 49,94 % |
| iShares Nasdaq 100 | -1,95 % | -2,62 % | 11,25 % | 77,36 % |
| iShares Nikkei 225® | -0,42 % | -9,42 % | 24,93 % | 51,28 % |
| iShares S&P 500 | -1,20 % | -2,99 % | 7,52 % | 59,46 % |
Comments by klostergang for this prediction
In the thread Travere Therapeutics Inc. diskutieren
Retrophin mit FDA-Zulassung zur Behandlung von Cystinurie und
fortgeschrittener pipeline: